ARYLOMYCIN-B2
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 53or73d9ta6 |
|---|---|
| InChI | InChI=1S/C42H59N7O13/c1-23(2)13-11-9-7-8-10-12-14-34(52)47(5)32(22-50)40(57)44-24(3)38(55)43-21-35(53)48(6)36-27-15-16-33(51)28(20-27)29-17-26(19-31(37(29)54)49(61)62)18-30(42(59)60)46-39(56)25(4)45-41(36)58/h15-17,19-20,23-25,30,32,36,50-51,54H,7-14,18,21-22H2,1-6H3,(H,43,55)(H,44,57)(H,45,58)(H,46,56)(H,59,60)/t24-,25-,30?,32-,36?/m0/s1 |
| InChIKey | WFBZGMGSCAVZTQ-BYBSAUBOSA-N |
| Mol Weight | 870.0 g/mol |
| Molecular Formula | C42H59N7O13 |
| Exact Mass | 869.417085 g/mol |
| Enantiomer InChIKey | WFBZGMGSCAVZTQ-ICOIEIGXSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
TAMANDARIN-A
3-Chloro-8,9-dimethoxy-5-phenyl-5,11-dihydroisoindolo[2,1-a]quinazoline
(2'S)-2'-HYDROXY-7-O-METHYLALLOPEUCENIN-2'-O-BETA-D-GLUCOPYRANOSIDE
2-(4-chlorophenyl)-2-oxoethyl 3-(4-methyl-1,3-dioxo-1,3-dihydro-2H-pyrrolo[3,4-c]quinolin-2-yl)benzoate
1,4,7-Trimethyl-10,10-bis(phenylmethyl)-2,4,6,8,9-pentazatricyclo[5.2.1.0(2,6)]dec-8-ene-3,5-dione
2-[Benzoyl-(4-chloro-phenyl)-amino]-3-butyl-3,4-dihydro-quinazoline-4-carboxylic acid tert-butylamide
LYNGBYAZOTHRIN_B
pyrazolo[1,5-a]pyrido[3,4-e]pyrimidin-6(7H)-one, 2-ethyl-3-(4-fluorophenyl)-7-(4-methoxyphenyl)-
2H-indol-2-one, 1-[(2-chlorophenyl)methyl]-1,3-dihydro-3-hydroxy-3-[2-(1-naphthalenyl)-2-oxoethyl]-
1-ETHYL-N,3-DIMETHYL-4-NITRO-N-(1-PHENYL-3-METHYL-4-CARBETHOXY-1H-PYRAZOL-5-YL)-1H-PYRAZOLE-5-CARBOXAMIDE
| Title | Journal or Book | Year |
|---|---|---|
| Arylomycins A and B, New Biaryl-bridged Lipopeptide Antibiotics Produced by Streptomyces sp. Tue 6075. II. Structure Elucidation. | The Journal of Antibiotics | 2002 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.